These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15903281)

  • 1. The influence of celecoxib on muscle fatigue resistance and mobility in elderly patients with inflammation.
    Mets T; Bautmans I; Njemini R; Lambert M; Demanet C
    Am J Geriatr Pharmacother; 2004 Dec; 2(4):230-8. PubMed ID: 15903281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects on muscle performance of NSAID treatment with piroxicam versus placebo in geriatric patients with acute infection-induced inflammation. A double blind randomized controlled trial.
    Beyer I; Bautmans I; Njemini R; Demanet C; Bergmann P; Mets T
    BMC Musculoskelet Disord; 2011 Dec; 12():292. PubMed ID: 22208783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of eicosapentaenoic and docosahexaenoic n-3 fatty acids from fish oil and preferential Cox-2 inhibition on systemic syndromes in patients with advanced lung cancer.
    Cerchietti LC; Navigante AH; Castro MA
    Nutr Cancer; 2007; 59(1):14-20. PubMed ID: 17927497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the selective COX-2 inhibitors, celecoxib and rofecoxib in rat acute models of inflammation.
    Pinheiro RM; Calixto JB
    Inflamm Res; 2002 Dec; 51(12):603-10. PubMed ID: 12558194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of rofecoxib, celecoxib, and acetaminophen in osteoarthritis of the knee: a randomized trial.
    Geba GP; Weaver AL; Polis AB; Dixon ME; Schnitzer TJ;
    JAMA; 2002 Jan; 287(1):64-71. PubMed ID: 11754710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the COX-2 inhibitor celecoxib on behavioural and immune changes in an olfactory bulbectomised rat model of depression.
    Myint AM; Steinbusch HW; Goeghegan L; Luchtman D; Kim YK; Leonard BE
    Neuroimmunomodulation; 2007; 14(2):65-71. PubMed ID: 17713352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of lumiracoxib in the treatment of osteoarthritis of the knee: a 13-week, randomized, double-blind comparison with celecoxib and placebo.
    Sheldon E; Beaulieu A; Paster Z; Dutta D; Yu S; Sloan VS
    Clin Ther; 2005 Jan; 27(1):64-77. PubMed ID: 15763607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of rofecoxib, celecoxib, and acetaminophen in patients with osteoarthritis of the knee. A combined analysis of the VACT studies.
    Schnitzer TJ; Weaver AL; Polis AB; Petruschke RA; Geba GP;
    J Rheumatol; 2005 Jun; 32(6):1093-105. PubMed ID: 15940774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of celecoxib on inflammatory markers in bipolar patients undergoing electroconvulsive therapy: a placebo-controlled, double-blind, randomised study.
    Kargar M; Yousefi A; Mojtahedzadeh M; Akhondzadeh S; Artounian V; Abdollahi A; Ahmadvand A; Ghaeli P
    Swiss Med Wkly; 2014 Feb; 144():w13880. PubMed ID: 24554598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of selective cyclooxygenase-2 inhibitor and omega-3 fatty acid on serum interleukin-1beta, osteocalcin, and C-reactive protein levels in rats.
    Vardar-Sengül S; Buduneli N; Buduneli E; Baylas H; Atilla G; Lappin D; Kinane DF
    J Periodontol; 2006 Apr; 77(4):657-63. PubMed ID: 16584347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating acute phase mediators and skeletal muscle performance in hospitalized geriatric patients.
    Bautmans I; Njemini R; Lambert M; Demanet C; Mets T
    J Gerontol A Biol Sci Med Sci; 2005 Mar; 60(3):361-7. PubMed ID: 15860475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective COX-2 inhibition improves endothelial function in coronary artery disease.
    Chenevard R; Hürlimann D; Béchir M; Enseleit F; Spieker L; Hermann M; Riesen W; Gay S; Gay RE; Neidhart M; Michel B; Lüscher TF; Noll G; Ruschitzka F
    Circulation; 2003 Jan; 107(3):405-9. PubMed ID: 12551863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomised controlled phase II trial of pre-operative celecoxib treatment reveals anti-tumour transcriptional response in primary breast cancer.
    Brandão RD; Veeck J; Van de Vijver KK; Lindsey P; de Vries B; van Elssen CH; Blok MJ; Keymeulen K; Ayoubi T; Smeets HJ; Tjan-Heijnen VC; Hupperets PS
    Breast Cancer Res; 2013 Apr; 15(2):R29. PubMed ID: 23566419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, clinical trial comparing oral celecoxib 200 mg, celecoxib 400 mg, and ibuprofen 600 mg for acute pain.
    Salo DF; Lavery R; Varma V; Goldberg J; Shapiro T; Kenwood A
    Acad Emerg Med; 2003 Jan; 10(1):22-30. PubMed ID: 12511311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of a selective cyclooxygenase-2 inhibitor (celecoxib) on chronic periodontitis.
    Yen CA; Damoulis PD; Stark PC; Hibberd PL; Singh M; Papas AS
    J Periodontol; 2008 Jan; 79(1):104-13. PubMed ID: 18166099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer.
    Liao Z; Komaki R; Milas L; Yuan C; Kies M; Chang JY; Jeter M; Guerrero T; Blumenschien G; Smith CM; Fossella F; Brown B; Cox JD
    Clin Cancer Res; 2005 May; 11(9):3342-8. PubMed ID: 15867233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of cyclooxygenase-2 inhibition on acute and chronic donor-site pain after spinal-fusion surgery.
    Reuben SS; Ekman EF; Raghunathan K; Steinberg RB; Blinder JL; Adesioye J
    Reg Anesth Pain Med; 2006; 31(1):6-13. PubMed ID: 16418018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic anti-hyperalgesia of electroacupuncture and low dose of celecoxib in monoarthritic rats: involvement of the cyclooxygenase activity in the spinal cord.
    Mi WL; Mao-Ying QL; Liu Q; Wang XW; Wang YQ; Wu GC
    Brain Res Bull; 2008 Sep; 77(2-3):98-104. PubMed ID: 18721668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Celecoxib does not affect the release of hyaluronic acid in end stage osteoarthritic joints.
    Takahashi D; Majima T; Onodera T; Kasahara Y; Inoue M; Irie T; Kasemura T
    Mod Rheumatol; 2013 Sep; 23(5):934-8. PubMed ID: 23001685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of comparative pain relief and tolerability of SKI306X compared with celecoxib in patients with rheumatoid arthritis: a 6-week, multicenter, randomized, double-blind, double-dummy, phase III, noninferiority clinical trial.
    Song YW; Lee EY; Koh EM; Cha HS; Yoo B; Lee CK; Baek HJ; Kim HA; Suh Y; Kang SW; Lee YJ; Jung HG
    Clin Ther; 2007 May; 29(5):862-873. PubMed ID: 17697905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.